| BE0319-25MG
| InVivoMAb anti-mouse FasL (CD178)
| 25 mg
| BioXCell
| in vivo FasL blockade, In vitro FasL blockade, Fun
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0345-5MG
| InVivoMAb anti-mouse/rat/bovine VLDL-R
| 5 mg
| BioXCell
| Western blot
|
| Mouse
| Goat, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0301-25MG
| InVivoMAb human IgG2 isotype control
| 25 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0319-100MG
| InVivoMAb anti-mouse FasL (CD178)
| 100 mg
| BioXCell
| in vivo FasL blockade, In vitro FasL blockade, Fun
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0346-50MG
| InVivoMAb anti-mouse CD326 (EpCAM)
| 50 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0310-100MG
| InVivoMAb anti-mouse VISTA
| 100 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0337-25MG
| InVivoMAb anti-mouse CD96
| 25 mg
| BioXCell
| in vivo CD96 blocking, in vitro CD96 blocking, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0318-25MG
| InVivoMAb anti-human Ganglioside GD2
| 25 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0330-5MG
| InVivoMAb anti-mouse CD69
| 5 mg
| BioXCell
| in vivo down-regulation of CD69 expression, Functi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0300-25MG
| InVivoMAb anti-mouse CD45.2
| 25 mg
| BioXCell
| Flow cytometry, in vivo CD45.2 blockade, in vitro
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0352-5MG
| InVivoMAb anti-mouse E-Cadherin (CD324)
| 5 mg
| BioXCell
| in vivo E-Cadherin neutralization, In vitro E-Cadh
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0353-1MG
| InVivoMAb anti-mouse/human/rat/monkey ICOS (CD278)
| 1 mg
| BioXCell
| in vitro T cell stimulation/activation, Flow cytom
|
| Armenian Hamster
| Human, Monkey, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0378-5MG
| InVivoMAb anti-mouse CD16.2 (Fc?RIV)
| 5 mg
| BioXCell
| in vivo CD16.2 blockade, in vitro CD16.2 blockade,
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0345-100MG
| InVivoMAb anti-mouse/rat/bovine VLDL-R
| 100 mg
| BioXCell
| Western blot
|
| Mouse
| Goat, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0335-25MG
| InVivoMAb anti-human MAGE-C2 (CT10)
| 25 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunofluorescenc
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0307-5MG
| InVivoMAb anti-mouse CD16/CD32
| 5 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0354-1MG
| InVivoMAb anti-human CD2
| 1 mg
| BioXCell
| in vivo CD2 blockade in huCD2tg mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0365-100MG
| InVivoMAb anti-mouse CD80 (B7-1)
| 100 mg
| BioXCell
| in vivo CD80 blockade, in vitro CD80 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0326-100MG
| InVivoMAb anti-mouse IL-27 p28
| 100 mg
| BioXCell
| in vivo IL-27 p28 neutralization, in vitro IL-27 p
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0331-5MG
| InVivoMAb anti-rat/mouse CD71 (TfR1)
| 5 mg
| BioXCell
| Targeted drug delivery to the brain, Immunohistoch
|
| Mouse
| Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0350-50MG
| InVivoMAb anti-mouse/human PrP (prion protein)
| 50 mg
| BioXCell
| in vivo PrP blocking, Western blot
|
| Mouse
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0319-1MG
| InVivoMAb anti-mouse FasL (CD178)
| 1 mg
| BioXCell
| in vivo FasL blockade, In vitro FasL blockade, Fun
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0320-1MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 1 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0320-25MG
| InVivoMAb anti-mouse Ly6G/Ly6C
| 25 mg
| BioXCell
| in vivo neutrophil depletion, Immunohistochemistry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0297-50MG
| InVivoMAb human IgG1 isotype control
| 50 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0351-1MG
| InVivoMAb anti-human NKG2D (CD314)
| 1 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0322-100MG
| InVivoMAb anti-mouse CD172a (SIRP?)
| 100 mg
| BioXCell
| in vivo SIRP? blocking, In vitro SIRP? blocking, W
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0372-100MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 100 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0362-25MG
| InVivoMAb anti-human CEACAM 1/3/5/6/8
| 25 mg
| BioXCell
| Western blot, ELISA, Immunofluorescence, Immunohis
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0366-25MG
| InVivoMAb mouse IgG2c isotype control, anti-dengue virus
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BE0357-1MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope A)
| 1 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0299-1MG
| InVivoMAb anti-mouse CD200 (OX2)
| 1 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0328-100MG
| InVivoMAb anti-mouse CD28
| 100 mg
| BioXCell
| in vivo T cell stimulation/activation, in vitro T
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0360-50MG
| InVivoMAb anti-mouse CD24
| 50 mg
| BioXCell
| in vivo administration, Immunohistochemistry (froz
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0367-100MG
| InVivoMAb anti-human CD71 (TfR1)
| 100 mg
| BioXCell
| in vitro CD71 targeting, in vivo CD71 targeting, I
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0353-100MG
| InVivoMAb anti-mouse/human/rat/monkey ICOS (CD278)
| 100 mg
| BioXCell
| in vitro T cell stimulation/activation, Flow cytom
|
| Armenian Hamster
| Human, Monkey, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0325-25MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 25 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0313-10MG
| InVivoMAb anti-mouse IL-23 (p19)
| 10 mg
| BioXCell
| in vivo IL-23p19 neutralization, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0375-5MG
| InVivoMAb anti-human EGFR
| 5 mg
| BioXCell
| in vivo EGFR blockade in xenografts, in vitro EGFR
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0343-100MG
| InVivoMAb anti-human CD71 (TfR)
| 100 mg
| BioXCell
| Western blot, Immunoprecipitation, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0358-50MG
| InVivoMAb anti-SARS-CoV-2 S protein (NTD)
| 50 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0329-100MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 100 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-25MG
| InVivoMAb anti-human NKG2D (CD314)
| 25 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0342-50MG
| InVivoMAb recombinant Flt-3L-Ig (hum/hum)
| 50 mg
| BioXCell
|
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| BE0326-5MG
| InVivoMAb anti-mouse IL-27 p28
| 5 mg
| BioXCell
| in vivo IL-27 p28 neutralization, in vitro IL-27 p
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0318-50MG
| InVivoMAb anti-human Ganglioside GD2
| 50 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0312-100MG
| InVivoMAb anti-mouse IFN?
| 100 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0353-25MG
| InVivoMAb anti-mouse/human/rat/monkey ICOS (CD278)
| 25 mg
| BioXCell
| in vitro T cell stimulation/activation, Flow cytom
|
| Armenian Hamster
| Human, Monkey, Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0306-50MG
| InVivoMAb anti-human/monkey MHC class II (HLA-DR)
| 50 mg
| BioXCell
| in vitro blocking of MHC class II HLA-DR, HLA clas
|
| Mouse
| Human, Monkey
| Solicitar Precio
| Solicitar
|
| BE0362-5MG
| InVivoMAb anti-human CEACAM 1/3/5/6/8
| 5 mg
| BioXCell
| Western blot, ELISA, Immunofluorescence, Immunohis
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|